London, United Kingdom, October 15, 2015 --(PR.com
)-- With the continual growth of biological drugs, the global market for pre-filled syringes is forecasted to rise to $6.6bn by 2020, exceeding a CAGR of 10%*. Pharma and medical device manufacturers have been eager to tap into this lucrative market. Nonetheless, evolving regulations, syringe material selection and stability still remain key hurdles for PFS market participants to overcome.
Juha Mattila, Senior Product Manager, STERIS Corporation said in his interview to SMi: “Looking into 2016, PFS-related products demand will continue to grow, thanks to development of new and sensitive drugs such as biologics, protein-based drugs. For example, the industry is moving towards self-injections, more complex delivery methods, and mixing devices for different purposes. Thanks to pre-filled technology, new advancements like this include improved dosage accuracy.”
Over 100+ representatives from the world’s leading Pharmaceutical and Biotechnology businesses will gather in London on the 27th-28th of January 2016, at the SMi Group’s 8th annual Pre-Filled Syringes Conference and Exhibition, to discuss the upcoming obstacles and the solutions which can be explored to accelerate pre-filled syringes development and technology advancements.
The 2016 agenda includes 16+ case studies from PFS leaders, 2 exclusive interactive workshops and over 4hrs unrivalled networking time. Further information available at the event website www.pre-filled-syringes.com/prcom
A complimentary copy of the event brochure with agenda breakdown, information on workshops and registration can be accessed at www.pre-filled-syringes/com/prcom
Highlights of attending Pre-Filled Syringes 2016 will include: a spotlight case study from F. Hoffmann-La Roche on usability challenges of PFS on combination products; Amgen to demonstrate how human factor engineering can reduce risks by design; Sanofi R&D showcasing the path to auto injectors; Allergan to explain their safety assessment of E&L when developing PFS drug products and GSK presenting on how to conduct thorough visual inspection of PFS.
Exclusive speaker line up 2016 also includes leading pre-filled syringes, device development and human factor engineers from MHRA, Sandoz, Barts Health Pharmaceuticals and many more.
Richard Featherstone, Managing Director, Medical Device Usability, said in his interview to SMi: “I’m interested in how manufacturers and industry are addressing the dilemma of legacy syringes with respect to human factor requirements. HF is a fast changing field and we can all learn from each other. Through the open discussions at Pre-Filled Syringes 2016, I am sure we will share ideas on improving device design which will benefit the patients and also meet regulators’ expectations!”
The event programme 2016 also offers two exclusive interactive half-day pre-conference workshops: “Pre-Filled Syringes: Development, Packaging and Regulatory Considerations” (led by Horst Koller, CEO, KH Packaging Consulting GmbH) and “Bridging the Gap - From Formulation to PFS Device Engineering” (led by Jean-Rene Authelin, Global Head, Pharmaceutical Engineering, Sanofi R&D).
They limit the number for pre-conference workshop. Early registration is strongly advised, please contact Fatega Begum on +44 (0) 207 827 6184 or register online at www.pre-filled-syringes/com/prcom
Stephen Morley, Vice President, Sales & Service, Noxilizer, commented: “If you are active in this market, we would strongly urge you to mark your diary and join us at this ground-breaking event that will provide you with hours of networking with leading experts in the pre-filled syringes marketplace.”
This years’ conference is proudly sponsored by BD, Medical Device Usability, Mitsubishi Gas Chemical, Nemera, Nipro, Noxilizer, Owen Mumford, Steris, West Pharmaceutical Services. Limited sponsorship opportunities available. For further information contact Alia Malick, Director, SMi, on +44 (0) 207 827 6168 or e-mail email@example.com
8th annual Pre-Filled Syringes Conference
27th - 28th January 2016
Contact e-mail: firstname.lastname@example.org
Contact number: Fateja Begum: +44 (0) 20 7827 6184
Source: * bit.ly/1LmL5tH
------------------------- END OF PRESS RELEASE--------------------------